TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33401279

Group type: EXPERIMENTAL
Intervention: Dupilumab plus narrow-band UVB (NB-UVB) phototherapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dupilumab alone
Number of subjects: 45
Study: 33082492

Group type: EXPERIMENTAL
Intervention: Lifestyle-induced weight loss intervention over 6 months
Number of subjects: 39
Study: 33017047

Group type: EXPERIMENTAL
Intervention: 20 mg ketamine
Number of subjects: 22

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 22
Study: 32176813

Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance and impact training (HiRIT)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Machine-based isometric axial compression (IAC)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 93
Study: 35276467

Group type: EXPERIMENTAL
Intervention: Saliravira® package plus routine treatments of COVID-19
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatments of COVID-19 alone
Number of subjects: 0
Study: 35241145

Group type: EXPERIMENTAL
Intervention: remifentanil-propofol combined with dexmedetomidine
Number of subjects: 120
Study: 32486877

Group type: COMPARATOR
Intervention: Serum total bilirubin tertile 3 (12.9–34.1 μmol/L)
Number of subjects: 19906

Group type: COMPARATOR
Intervention: Direct bilirubin tertile 3 (2.5–24.8 μmol/L)
Number of subjects: 19906
Study: 33934412

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transfer (FMT)
Number of subjects: 11
Study: 35443304

Group type: EXPERIMENTAL
Intervention: School meals (Nutrition Improvement Program)
Number of subjects: 26778
Study: 33258355

Group type: EXPERIMENTAL
Intervention: Traditional Chinese exercises combined with traditional Chinese massage
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional Chinese exercises
Number of subjects: 70
Study: 34047839

Group type: EXPERIMENTAL
Intervention: VITOM 3D exoscope
Number of subjects: 71

Group type: COMPARATOR
Intervention: Operating microscope
Number of subjects: 71
Study: 33555697

Group type: EXPERIMENTAL
Intervention: Exposure treatment (10 to 15 sessions)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Behavioral Avoidance Test‐Back Pain (BAT‐Back) score >22
Number of subjects: 43
Study: 35299177

Group type: EXPERIMENTAL
Intervention: Carboplatin plus paclitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Site-specific therapy based on gene expression profiling (GEP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study: 32114531

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 286

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 286
Study: 35751858

Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 0
Study: 32205375

Group type: EXPERIMENTAL
Intervention: OnTrack intervention (software for smart devices and coaching support)
Number of subjects: 12
Study: 35595223

Group type: COMPARATOR
Intervention: hCG alone (6000 IU)
Number of subjects: 510

Group type: COMPARATOR
Intervention: GnRHa alone (0.2 mg of triptorelin)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Dual trigger (0.2 mg of triptorelin plus 2000 IU of hCG)
Number of subjects: 510
Study: 34735862

Group type: EXPERIMENTAL
Intervention: Targeted education on the use of oral HIV self-test kits for their partners, along with up to five oral HIV self-test kits.
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control group received partner notification services only.
Number of subjects: 326
Study: 34674160

Group type: EXPERIMENTAL
Intervention: IDP-126 (clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15%)
Number of subjects: 741

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 741

Group type: COMPARATOR
Intervention: BPO/adapalene
Number of subjects: 741

Group type: COMPARATOR
Intervention: clindamycin phosphate/BPO
Number of subjects: 741

Group type: COMPARATOR
Intervention: clindamycin phosphate/adapalene
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: IDP-126
Number of subjects: 741

Group type: COMPARATOR
Intervention: Vehicle or dyads
Number of subjects: 741
Study: 32220260

Group type: EXPERIMENTAL
Intervention: Intraperitoneal Ethanol (ET)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intraperitoneal Sodium Pentobarbital (PB)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intraperitoneal Sodium Pentobarbital (PB) with anesthesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intrahepatic Sodium Pentobarbital (PB)
Number of subjects: 80
Study: 35341337

Group type: EXPERIMENTAL
Intervention: Home phototherapy
Number of subjects: 8
Study: 32430507

Group type: EXPERIMENTAL
Intervention: EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin)
Number of subjects: 90

Group type: COMPARATOR
Intervention: EPOCH-vorinostat (EPOCH plus 300 mg vorinostat on days 1 to 5 of each cycle)
Number of subjects: 90

Group type: COMPARATOR
Intervention: EPOCH-vorinostat
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: EPOCH
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Patients with Myc+ DLBCL
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Patients with CD4+ count <200 cells/mm3
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low diagnosis-to-treatment interval (DTI)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Preprotocol therapy
Number of subjects: 90
Study: 35983429

Group type: EXPERIMENTAL
Intervention: IV lidocaine (1.5 mg kg−1 followed by 4 mg kg−1 h−1 continuous infusion)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: IV lidocaine
Number of subjects: 140
Study: 34759182

Group type: EXPERIMENTAL
Intervention: High-molecular-weight hyaluronate injection (20 mg)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight hyaluronate injection (20 mg)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Physical Therapy (10 sessions)
Number of subjects: 79
Study: 33141096

Group type: EXPERIMENTAL
Intervention: LungTalk - a web-based tailored computer program (n=31)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Generic information about lung cancer screening from the American Cancer Society (n=29)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LungTalk
Number of subjects: 60
Study: 35712892

Group type: EXPERIMENTAL
Intervention: Flexible take-home dosing buprenorphine/naloxone
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Supervised methadone models of care
Number of subjects: 269
Study: 32054507

Group type: EXPERIMENTAL
Intervention: Tianzhi granule (TZ)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 543

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 543
Study: 35276813

Group type: EXPERIMENTAL
Intervention: ONE: 45 min/d continuous brisk walking bout
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MICRO: 5 min brisk walking each hour for 9 h
Number of subjects: 19

Group type: COMPARATOR
Intervention: SED: Sedentary control
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: ONE and MICRO
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: ONE
Number of subjects: 19
Study: 33040362

Group type: EXPERIMENTAL
Intervention: Early egg introduction
Number of subjects: 206

Group type: COMPARATOR
Intervention: No early egg introduction
Number of subjects: 206
Study: 32727601

Group type: EXPERIMENTAL
Intervention: Self-care counselling
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 76
Study: 35617287

Group type: COMPARATOR
Intervention: Early mobilization (EM)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Early mobilization combined with early nutrition (EMN)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Routine care (Control)
Number of subjects: 150
Study: 34789316

Group type: EXPERIMENTAL
Intervention: Knee instability (KI) group (n=26)
Number of subjects: 57

Group type: COMPARATOR
Intervention: No knee instability group (n=31)
Number of subjects: 57
Study: 34377358

Group type: EXPERIMENTAL
Intervention: PM+ with care-as-usual (CAU)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: PM+ with Emotional Processing (PM+EP) with CAU
Number of subjects: 90

Group type: COMPARATOR
Intervention: CAU only
Number of subjects: 90
Study: 36414833

Group type: EXPERIMENTAL
Intervention: Exercise plus energy restriction (EXER)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Energy restriction only (ER)
Number of subjects: 60
Study: 32691178

Group type: EXPERIMENTAL
Intervention: Low-dose methadone (LDM)
Number of subjects: 30
Study: 36046452

Group type: EXPERIMENTAL
Intervention: GA+SA
Number of subjects: 50
Study: 34938043

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections (BTX)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Conventional occlusal stents
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (removal of OD at night)
Number of subjects: 42
Study: 36483295

Group type: EXPERIMENTAL
Intervention: NESA neuromodulation treatment (NNT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study: 32282852

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 967

Group type: EXPERIMENTAL
Intervention: Metformin 1,700 mg/day
Number of subjects: 967

Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg/day
Number of subjects: 967

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of linagliptin/metformin
Number of subjects: 967
Study: 36035839

Group type: EXPERIMENTAL
Intervention: Case-based teaching method based on primary teaching principle
Number of subjects: 126

Group type: COMPARATOR
Intervention: Traditional teaching approach
Number of subjects: 126
Study: 32932369

Group type: EXPERIMENTAL
Intervention: TECNIS Eyhance IOL (Model ICB00)
Number of subjects: 139

Group type: COMPARATOR
Intervention: TECNIS Monofocal IOL (Model ZCB00)
Number of subjects: 139
Study: 33274667

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 36270225

Group type: COMPARATOR
Intervention: Arms free
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both arms constrained
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Contralateral arm constrained
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ipsilateral arm constrained
Number of subjects: 64
Study: 33358073

Group type: EXPERIMENTAL
Intervention: Fugl-Meyer Assessment of Lower Extremity (FMA-LE) scored by three experienced physical therapists
Number of subjects: 60
Study: 35664940

Group type: EXPERIMENTAL
Intervention: Acacia (Acacia nilotica Linn.) pod's sitz bath (30g) plus vaginal cotton pessary (5 ml) once daily for 10 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (palm sugar powder 30g solution for sitz bath plus vaginal cotton pessary same as Acacia group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Acacia group
Number of subjects: 66
Study: 32538007

Group type: EXPERIMENTAL
Intervention: Acupuncture plus western medication (levamlodipine maleate 2.5 mg once daily)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Acupuncture plus western medication
Number of subjects: 70

Group type: COMPARATOR
Intervention: Western medication (levamlodipine maleate 2.5 mg once daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Western medication
Number of subjects: 70
Study: 35324903

Group type: EXPERIMENTAL
Intervention: Removal of seasonal chocolate confectionery from prominent locations in intervention stores
Number of subjects: 185
Study: 32719045

Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone (250 mg on day 1 followed by 80 mg on days 2-5) with or without tocilizumab (8 mg/kg body weight, single infusion) if respiratory condition did not improve sufficiently (in 43%).
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone with or without tocilizumab.
Number of subjects: 172

Group type: COMPARATOR
Intervention: Supportive care only (historical control group).
Number of subjects: 172
Study: 34216815

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg/day
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg/three times-week
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg/once a week
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (full dose arm)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Safety
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Change in Ki-67
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Circulating sex hormones
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Adipokines
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lipid profile
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Insulin and glucose
Number of subjects: 180
Study: 32664003

Group type: EXPERIMENTAL
Intervention: Continuing sertraline
Number of subjects: 1544

Group type: EXPERIMENTAL
Intervention: Combining sertraline with mirtazapine
Number of subjects: 1544

Group type: EXPERIMENTAL
Intervention: Switching to mirtazapine after initial failure to remit on sertraline
Number of subjects: 1544
Study: 35550149

Group type: EXPERIMENTAL
Intervention: Saliva microbiome α-diversity (Shannon index)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Oral Veillonella nakazawae
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Gut Bacteroides thetaiotaomicron
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Short-chain fatty acid levels
Number of subjects: 59
Study: 32984992

Group type: EXPERIMENTAL
Intervention: Concrete conceptualization of GMOs
Number of subjects: 1470

Group type: COMPARATOR
Intervention: Abstract conceptualization of GMOs
Number of subjects: 1470
Study: 32741031

Group type: EXPERIMENTAL
Intervention: Warfarin (775 patients, INR goal 2.5)
Number of subjects: 1097

Group type: COMPARATOR
Intervention: No anticoagulation (322 patients)
Number of subjects: 1097
Study: 36058900

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Continuous paravertebral block (PVB)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Single-shot intercostal nerve block (ICNB)
Number of subjects: 450

Group type: COMPARATOR
Intervention: TEA
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: PVB
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: ICNB
Number of subjects: 450
Study: 33405993

Group type: EXPERIMENTAL
Intervention: TQ‐A3334 (0.2‐1.8 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: TQ‐A3334 (1.0 to 1.8 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: TQ‐A3334 (1.2 mg) with food
Number of subjects: 48
Study: 33554566

Group type: EXPERIMENTAL
Intervention: Low vitamin-D levels (<50 nmol/L)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal vitamin-D levels (>50 nmol/L)
Number of subjects: 50
Study: 34674368

Group type: EXPERIMENTAL
Intervention: 3 mg time-release melatonin
Number of subjects: 580

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 580
Study: 34608842

Group type: EXPERIMENTAL
Intervention: LY2940094
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 33028293

Group type: EXPERIMENTAL
Intervention: Reduced duration of antibiotic treatment
Number of subjects: 312

Group type: COMPARATOR
Intervention: Standard duration of antibiotic treatment (control group)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Biomarker levels (CRP, PCT, proADM) measured at admission, day 5, and day 30
Number of subjects: 312
Study: 35400033

Group type: EXPERIMENTAL
Intervention: Flipped classroom based on micro-video class
Number of subjects: 2

Group type: COMPARATOR
Intervention: Traditional teaching model
Number of subjects: 2
Study: 34819131

Group type: EXPERIMENTAL
Intervention: Lithium (300 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32777692

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone
Number of subjects: 508
Study: 35716317

Group type: EXPERIMENTAL
Intervention: Weight loss maintenance programme (WLM)
Number of subjects: 0
Study: 32524888

Group type: EXPERIMENTAL
Intervention: Elective replacement of peripheral intravenous cannula (72–96 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard replacement of peripheral intravenous cannula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elective replacement of peripheral intravenous cannula
Number of subjects: 0
Study: 32035412

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 202
Study: 36429385

Group type: EXPERIMENTAL
Intervention: Augmented reality exergame (Portable Exergame Platform for Elderly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cycle ergometer
Number of subjects: 0

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 0
Study: 33750673

Group type: EXPERIMENTAL
Intervention: aerobic and resistance training (MIX)
Number of subjects: 20

Group type: COMPARATOR
Intervention: stretching (CON)
Number of subjects: 20
Study: 36453237

Group type: EXPERIMENTAL
Intervention: Water Vapor Therapy (Rezum procedure)
Number of subjects: 426
Study: 33342254

Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 302
Study: 35507830

Group type: EXPERIMENTAL
Intervention: Exposure-based treatment for perfectionism
Number of subjects: 74

Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 74
Study: 34275562

Group type: EXPERIMENTAL
Intervention: Memantine 20 mg every 8 hours for five days, then 20 mg daily for three months
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard treatments
Number of subjects: 77
Study: 32388015

Group type: EXPERIMENTAL
Intervention: Conventional bike lanes
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Local roads with bicycle facilities
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Local roads without bicycle facilities or traffic calming
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Protected bike lanes with heavy separation
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Protected bike lanes with lighter separation (one way)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Protected bike lanes with lighter separation (two way)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Presence of streetcar or train tracks
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Downhill grades
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Temporary features blocking path
Number of subjects: 604
Study: 35502024

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (aPRP) eye drop
Number of subjects: 61

Group type: COMPARATOR
Intervention: Artificial tear (AT) eye drop
Number of subjects: 61
Study: 32276515

Group type: EXPERIMENTAL
Intervention: Xbox Kinect training (3 times per week, 50 min per session for 10 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Xbox Kinect training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (maintaining levels of physical activity)
Number of subjects: 40
Study: 35970354

Group type: EXPERIMENTAL
Intervention: Voiding Time (VT) in symptomatic men
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Voiding Time (VT) sensitivity analysis
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Maximum flow rates (Qmax) in symptomatic men
Number of subjects: 30

Group type: COMPARATOR
Intervention: Voiding Time (VT) vs Maximum flow rates (Qmax)
Number of subjects: 30
Study: 32179132

Group type: EXPERIMENTAL
Intervention: RCT plus hyperthermia (RCHT)
Number of subjects: 373

Group type: COMPARATOR
Intervention: RCT
Number of subjects: 373
Study: 36203828

Group type: EXPERIMENTAL
Intervention: Home-based transcranial direct current stimulation (tDCS) self-administered daily for 30 min with 2 mA
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 64
Study: 35454326

Group type: EXPERIMENTAL
Intervention: Co‐analgetic group (Co‐A) with systemic ketamine and lidocaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Epidural group (EA) with epidural analgesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard group (C) with perioperative opioids and metamizole/acetaminophen
Number of subjects: 80
Study: 35377106

Group type: EXPERIMENTAL
Intervention: Inhaled lavender essential oil (LEO)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (standard care with swaddling, oral sucrose, and sucking)
Number of subjects: 142
Study: 33026901

Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate
Number of subjects: 15982

Group type: EXPERIMENTAL
Intervention: Endoscopic enucleation
Number of subjects: 15982

Group type: EXPERIMENTAL
Intervention: Other transurethral procedures
Number of subjects: 15982

Group type: EXPERIMENTAL
Intervention: Endoscopic enucleation (2011-2012)
Number of subjects: 15982

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 15982
Study: 33038825

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (200 mg/kg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Betaine (2 g/kg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Combination of Ascorbic acid (200 mg/kg) and Betaine (2 g/kg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (basal diet only)
Number of subjects: 240
Study: 33836458

Group type: EXPERIMENTAL
Intervention: 50 Hz local vibration
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 100 Hz local vibration
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (exercise)
Number of subjects: 27
Study: 32945150

Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 674

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 674
Study: 36103158

Group type: EXPERIMENTAL
Intervention: Itraconazole 100 mg/d
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg/d
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg/d
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 149
Study: 34312921

Group type: EXPERIMENTAL
Intervention: 3 ml/kg 5% Dextrose
Number of subjects: 44

Group type: COMPARATOR
Intervention: 5 ml/kg 5% Dextrose
Number of subjects: 44
Study: 37675488

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 35074540

Group type: EXPERIMENTAL
Intervention: ABCDEF pulmonary rehabilitation program
Number of subjects: 90

Group type: COMPARATOR
Intervention: Regular care (control group)
Number of subjects: 90